NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Epigenetics and Heart Disease Risk with Cardio Diagnostics Holdings Inc. (CDIO)
Cardio Diagnostics Holdings Inc. uses epigenetics to assess heart disease risk beyond genetics, revealing how lifestyle and environment impact gene expression. This approach offers both diagnostic insight and potential solutions for cardiovascular health.
Cardio Diagnostics is a medical technology company that uses epigenetics-based cardiovascular testing to assess heart disease risk.
Genetics looks at the DNA sequence itself, while epigenetics examines how genes are turned on or off without changing the DNA code, influenced by lifestyle, behavior, and environment.
Epigenetics provides deeper insight into how lifestyle and environment affect gene expression, revealing hidden risks that DNA sequence alone may miss.
According to the CEO, epigenetics not only pinpoints problems but also provides some level of solution, suggesting actionable insights.
Family history plays a role, but research suggests DNA sequence alone tells only part of the story, with epigenetics potentially being the larger part.
The latest news and updates relating to CDIO are available in the company's newsroom at https://ibn.fm/CDIO.
MissionIR is a specialized communications platform that helps IR firms with syndicated content to enhance visibility for private and public companies within the investment community.